Capital Goods Healthcare Sector

Control Bionics

Market Cap: AU$9.1m

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.

Unified Global

Market Cap: US$5.9m

Operates as a vertically integrated cannabis company in Canada and the United States.

Channel Therapeutics

Market Cap: US$5.9m

A clinical-stage biotech company, develops and commercializes new therapeutics to alleviate pain.

Nymox Pharmaceutical

Market Cap: US$5.9m

A biopharmaceutical company, engages in the research and development of products for the aging population in Canada, the United States, and Europe.

Indaptus Therapeutics

Market Cap: US$5.9m

A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

Soligenix

Market Cap: US$5.9m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.

IM Cannabis

Market Cap: CA$8.1m

Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.

NLS Pharmaceutics

Market Cap: US$5.8m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.

Mobile-health Network Solutions

Market Cap: US$5.8m

An investment holding company, provides telehealth solutions primarily in Singapore.

TransCode Therapeutics

Market Cap: US$5.8m

A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.

Jaguar Health

Market Cap: US$5.7m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

Biofrontera

Market Cap: US$5.7m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Sigyn Therapeutics

Market Cap: US$5.7m

A development-stage company, provides therapeutic solutions to treat cancer and infectious disease disorders in the United States.

Rakovina Therapeutics

Market Cap: CA$7.7m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Sproutly Canada

Market Cap: CA$7.6m

Produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.

Pasithea Therapeutics

Market Cap: US$5.5m

A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

HealthLynked

Market Cap: US$5.5m

A healthcare technology company, operates a cloud-based patient information network and record archiving system in the United States.

Klotho Neurosciences

Market Cap: US$5.5m

Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.

Cannabis Bioscience International Holdings

Market Cap: US$5.5m

Cannabis Bioscience International Holdings, Inc.

American Films

Market Cap: US$5.4m

Does not have significant operations.

Argent BioPharma

Market Cap: AU$8.3m

A multidisciplinary drug development Company, engages in the provision of medicines targeting immunology and neurology worldwide.

DATATRAK International

Market Cap: US$5.4m

A technology and services company, provides unified clinical solutions and related services for the clinical trials industry.

StateHouse Holdings

Market Cap: CA$7.7m

An integrated omni-channel cannabis company, engages in the cultivation, processing, manufacture, distribution, and retailing of cannabis products for the adult-use and medical markets in the United States.

FutureNet

Market Cap: US$5.4m

This record represents the public shell of FutureNet Inc.

N4 Pharma

Market Cap: UK£4.0m

A specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.

NutraProducts

Market Cap: US$5.3m

A contract manufacturer, engages in the production of gummy supplements.

CompuMed

Market Cap: US$5.3m

An enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities.

Sunshine Biopharma

Market Cap: US$5.2m

Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Quoin Pharmaceuticals

Market Cap: US$5.2m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

Innovative Holdings Alliance

Market Cap: US$5.2m

A medical technology holding company, offers personal care products in North America.

Sonoma Pharmaceuticals

Market Cap: US$5.2m

Develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

HITIQ

Market Cap: AU$8.0m

Engages in development and commercialization of concussion management technology and software in Australia.

Kovo+ Holdings

Market Cap: CA$7.1m

Operates as a healthcare technology company.

Eyenovia

Market Cap: US$5.1m

An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.

Plus Therapeutics

Market Cap: US$5.1m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

BioCorRx

Market Cap: US$5.1m

Through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.